Evidence map›Paper›PMID 41131774›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2025

[Impact of palliative care on medication use and medical utilization in patients with advanced cancer].

Dingyi Chen, Haoxin DU, Yichen Zhang, Yanfei Wang, Wei Liu, Yuanyuan Jiao, Luwen Shi, Xiaodong Guan, Xinpu Lu

Abstract readEnglish Abstract
PubMed Full text at PMC
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dingyi ChenDepartment of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical sciences, Beijing 100191, China.
Haoxin DUDepartment of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical sciences, Beijing 100191, China.
Yichen ZhangDepartment of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical sciences, Beijing 100191, China.
Yanfei WangKey Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing 100142, China.
Wei LiuKey Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing 100142, China.
Yuanyuan JiaoKey Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing 100142, China.
Luwen ShiDepartment of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical sciences, Beijing 100191, China.
Xiaodong GuanDepartment of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical sciences, Beijing 100191, China.
Xinpu LuKey Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing 100142, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the effect of palliative care on drug use, medical service utilization and medical expenditure of patients with advanced cancer.

methodsA cohort of patients including pal-liative care and standard care was constructed using the medical records of the patients in Peking University Cancer Hospital from 2018 to 2020, and coarsened exact matching was used to match the two groups of patients. The average monthly opioid consumption, hospitalization rate, intensive care unit (ICU) rate and operation rate, and the average monthly total cost were selected to evaluate drug use, medical service utilization and medical expenditure. Chi-square test and Wilcoxon signed rank test were used to compare the differences between the two groups before and after exposure and the change in the palliative care group. The net impact of palliative care on the patients was calculated using the difference-in-differences analysis.

resultsIn this study, 180 patients in the palliative care group and 3 101 patients in the stan-dard care group were finally included in the matching, and the matching effect of the two groups was good (

conclusionPalliative care can increase the opioid consumption in advanced cancer patients, reduce the rates of hospitalization, ICU and surgery, but has no significant effect on medical expenditure.

Indexed as

Analgesics, OpioidDrug UtilizationNeoplasmsPalliative CarePatient Acceptance of Health CareAdultAgedFemaleHealth ExpendituresHospitalizationHumansIntensive Care UnitsMaleMiddle AgedAnalgesics, OpioidDrug utilizationMedical expenditureMedical service utilizationNeoplasmOpiumPalliative care

Identifiers

PMID41131774
PMCPMC12549369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.